Start with the answer that matters
Selank belongs to a group called peptides: short chains whose building blocks also form proteins.
It was developed in Russia as a drug for anxiety.
The US agency reviewing medicines, the Food and Drug Administration (FDA), says key information about harm from Selank in people is missing.
As of September 30, 2026, no Selank medicine had FDA approval in the United States.
That makes a conversation about your anxiety a more useful starting point than choosing a product. Write down what you want help with, even if the words feel rough.
Real studies, with real limits
Small Russian studies have looked at anxiety, but their limits leave the benefit of Selank uncertain.
The patient studies described here did not include a placebo group, meaning people given a dummy treatment for comparison.
A helpful question for a clinician is: which evidence fits the problem I am trying to solve? You do not need to learn the language of a lab to ask that.
Begin care with the concern you have
For a visit in person or online, begin with what has been hard and what you want help with. Ask what the assessment includes.
Medical-board guidance calls for the care standard to stay the same whether you meet online or in person.
That guidance calls for the clinician to arrange any needed examination or test, or refer you to someone who can.